Chemoinformaics analysis of Nitroblue Tetrazolium Chlorides
| Molecular Weight | 817.65 | nRot | 11 |
| Heavy Atom Molecular Weight | 787.41 | nRig | 48 |
| Exact Molecular Weight | 816.173 | nRing | 8 |
| Solubility: LogS | -9.212 | nHRing | 2 |
| Solubility: LogP | 8.424 | No. of Aliphatic Rings | 0 |
| Acid Count | 6 | No. of Aromatic Rings | 8 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 88 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 58 | No. of Aromatic Carbocycles | 6 |
| nHetero | 18 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 40 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 10 | No. of Arom Atom | 46 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 46 |
| nHA | 12 | APOL | 106.976 |
| nHD | 0 | BPOL | 40.4602 |
| QED | 0.084 |
| Synth | 3.428 |
| Natural Product Likeliness | -0.43 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.971 |
| HIA | 0.09 |
| CACO-2 | -5.241 |
| MDCK | 0.0000928 |
| BBB | 0.043 |
| PPB | 1.02346 |
| VDSS | 0.734 |
| FU | 0.00454866 |
| CYP1A2-inh | 0.327 |
| CYP1A2-sub | 0.129 |
| CYP2c19-inh | 0.617 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.933 |
| CYP2c9-sub | 0.953 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.315 |
| CYP3a4-inh | 0.666 |
| CYP3a4-sub | 0.915 |
| CL | 5.202 |
| T12 | 0.002 |
| hERG | 0.339 |
| Ames | 0.112 |
| ROA | 0.148 |
| SkinSen | 0.375 |
| Carcinogencity | 0.499 |
| EI | 0.863 |
| Respiratory | 0.162 |
| NR-Aromatase | 0.456 |
| Antiviral | Yes |
| Prediction | 0.644694 |